These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 28286630)

  • 1. Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-M Alloantibody in Myelofibrosis: A Case Report.
    Alsoreeky MS; Lutfi LK; Altamimi AA; Haddad TH; Khalayleh MS; Alkader MS
    Cureus; 2023 Dec; 15(12):e50717. PubMed ID: 38234941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series.
    Lapite A; Bhar S; Fasipe T
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31061. PubMed ID: 38840429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhemolysis in a patient with beta-thalassemia major.
    Morawakage LR; Perera BJ; Dias PD; Wijewardana SK
    Asian J Transfus Sci; 2009 Jan; 3(1):26-7. PubMed ID: 20041094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic recovery in systemic nontraumatic fat embolism syndrome in an elderly patient with hemoglobin SC disease: A case report.
    Ositelu A; Urrutia-Argueta S; Kapoor R
    Clin Case Rep; 2020 Sep; 8(9):1816-1820. PubMed ID: 32983503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhemolysis syndrome in a case of sickle cell disease.
    Dronamraju S; Irshad VS; Acharya S; Shukla S; Kumar S
    Asian J Transfus Sci; 2024; 18(1):155-156. PubMed ID: 39036684
    [No Abstract]   [Full Text] [Related]  

  • 6. Family reflections: bone marrow transplant offers new lease of life for some living with sickle cell disease.
    McDonald D
    Pediatr Res; 2024 Jun; ():. PubMed ID: 38918636
    [No Abstract]   [Full Text] [Related]  

  • 7. In Response to, "Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease".
    Johnson LM; Sharma A; Carroll Y; Goodson D; Mandrell B; Gattuso JS; Young AJ; Boggs J; Wilfond B; Unguru Y
    Blood Adv; 2024 Jun; ():. PubMed ID: 38865716
    [No Abstract]   [Full Text] [Related]  

  • 8. Rounding up sickle cells with gene therapy.
    Byrne L
    Sci Transl Med; 2017 Mar; 9(381):. PubMed ID: 28298423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-specific modeling of individual sickle cell behavior under transient hypoxia.
    Li X; Du E; Dao M; Suresh S; Karniadakis GE
    PLoS Comput Biol; 2017 Mar; 13(3):e1005426. PubMed ID: 28288152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.
    Madu AJ; Ugwu AO; Efobi C
    Med Princ Pract; 2021; 30(3):236-243. PubMed ID: 33176303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature.
    Menakuru SR; Priscu A; Dhillon V; Salih A
    Hematol Rep; 2022 Jul; 14(3):235-239. PubMed ID: 35893156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhemolysis in sickle cell disease.
    Aragona E; Kelly MJ
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e54-6. PubMed ID: 23619113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.
    Karafin MS; Singavi A; Johnson ST; Field JJ
    Hematol Rep; 2017 Feb; 9(1):6934. PubMed ID: 28286630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.